NCT03371888View on ClinicalTrials.gov

The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

December 7, 2017

Primary Completion Date

December 15, 2018

Study Completion Date

January 1, 2019

Conditions
PRPTemporomandibular DisorderMyalgiaBruxism
Interventions
BIOLOGICAL

Platelet-Rich Plasma intramuscular injections

A platelet-rich plasma intramuscular injections into the trigger points of painful muscles were performed.

BIOLOGICAL

Placebo Comparator: 0,9% NaCl intramuscular injections

A 0,9% NaCl intramuscular injections into the trigger points of painful muscles were performed.

Trial Locations (1)

41-800

Department of TMD Silesian Medical University, Zabrze

All Listed Sponsors
lead

Medical University of Silesia

OTHER

NCT03371888 - The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders | Biotech Hunter | Biotech Hunter